Consonance Capital Management as of March 31, 2016
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 22 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mallinckrodt Pub | 10.3 | $68M | 1.1M | 61.28 | |
| Orthofix International Nv Com Stk | 9.5 | $63M | 1.5M | 41.52 | |
| Medivation | 9.4 | $62M | 1.4M | 45.98 | |
| Ironwood Pharmaceuticals (IRWD) | 8.2 | $54M | 4.9M | 10.94 | |
| Merrimack Pharmaceuticals In | 7.4 | $49M | 5.9M | 8.37 | |
| NuVasive | 7.4 | $49M | 1.0M | 48.65 | |
| Abbvie (ABBV) | 7.2 | $48M | 833k | 57.12 | |
| DepoMed | 5.8 | $38M | 2.8M | 13.93 | |
| Pacific Biosciences of California (PACB) | 5.8 | $38M | 4.5M | 8.50 | |
| Retrophin | 5.6 | $37M | 2.7M | 13.66 | |
| Ariad Pharmaceuticals | 5.4 | $36M | 5.6M | 6.39 | |
| Biosante Pharmaceuticals (ANIP) | 5.2 | $35M | 1.0M | 33.66 | |
| Eagle Pharmaceuticals (EGRX) | 4.2 | $28M | 694k | 40.50 | |
| Allergan | 3.9 | $26M | 95k | 268.03 | |
| Vericel (VCEL) | 2.0 | $13M | 2.2M | 5.86 | |
| Adma Biologics (ADMA) | 1.3 | $8.6M | 1.1M | 8.09 | |
| Seaspine Holdings | 0.4 | $2.4M | 167k | 14.64 | |
| Axogen (AXGN) | 0.3 | $2.2M | 406k | 5.36 | |
| Penumbra (PEN) | 0.3 | $1.8M | 40k | 46.00 | |
| Biolase Technology | 0.2 | $1.6M | 1.3M | 1.31 | |
| Veracyte (VCYT) | 0.1 | $896k | 166k | 5.40 | |
| Derma Sciences | 0.0 | $5.5k | 182k | 0.03 |
